Current Members

PPTA members produce approximately 80% of the plasma protein therapies used in the United States today and more than 60% worldwide.

Global Members

Bio Products Laboratory
Biotest
CSL Behring
Grifols
Kedrion SpA
Takeda

European Members

Bio Products Laboratory
Biotest AG
CSL Behring GmbH
Grifols International SA
Kedrion SpA
Takeda

North America Members

ADMA Biologics, Inc.
Bio Products Laboratory
CSL Behring
Emergent BioSolutions
Grifols
Kedrion SpA
Takeda

Source Members

Access Plasma LLC
B Positive Plasma LLC
BioLife Plasma Services LP/(Takeda)
Biotest Pharmaceuticals
Blood and Plasma Research Inc.
BPL Plasma Inc.
Canadian Plasma Resources
Cara Plasma s.r.o
CSL Plasma
Europlasma GmbH
GCAM Inc.
Grifols Plasma
Haema AG
Hemarus LLC
Immunotek Bio Centers LLC
KEDPlasma LLC
Kedrion SpA
Octapharma Plasma
Plasmaspendedienst Graz
PlasmaVita
Prometic Plasma Resources
Ruhr Plasma GmbH
Scantibodies Biologics
Southern Blood Services
UNICAplasma s.r.o

Associate Members

Abbott Laboratories Diagnostic Division
ABO Pharmaceuticals
AOSS Medical Supply
Blood Centers of America (BCA)
Fresenius Kabi
Haemonetics Corporation
Hemasource
Kamada Ltd.
Lychem International Ltd.
Marketing Research Bureau Inc.
National Genetics Institute
Paysign, Inc.
PreviPharma Consulting GmbH
QualTex Laboratories
Roche Diagnostics
Secure Transfusion Services
Therapure Biopharma Inc.
Vizient Inc.
Wirecard North America

Membership

PPTA News

PPTA Repeats Appeals for Plasma Donations +

The Plasma Protein Therapeutics Association is steadfast in its mission to promote the availability of, and access to, safe and effective plasma protein therapies for patients around the world. We call on all eligible adults to donate plasma – whether you are someone recovered from COVID-19 or not, your plasma is needed to save lives, now. By donating plasma today, you are directly helping to save the lives of babies born with primary immune deficiencies, bleeding disorders, and other rare conditions, as well as patients who rely on plasma therapies in emergency and critical-care contexts.
Read More
White House Roundtable: “We’re in this Together” +

Yesterday, President Trump, senior officials within his Administration, and representatives from the plasma and blood communities agreed that plasma donation is a national imperative, recognizing how essential plasma is and urging Americans to donate their plasma. Paul Perreault, Chief Executive Officer and Managing Director of CSL Ltd. represented the CoVIg-19 Alliance, “an unprecedented partnership of world-leading companies” dedicated to the development of a hyperimmune globulin with the potential to treat people seriously impacted by COVID-19. He took the opportunity presented by participating in the White House Roundtable to issue a call for all Americans to donate plasma, even those who have not had COVID-19, and to urge the Administration to support the industry’s effort to develop a hyperimmune to combat COVID-19.
Read More
PPTA Responds to July 24 White House Executive Orders +

White House executive orders issued on July 24 calling for a “favored nations” and drug importation program are ill-advised and risk the lives of U.S. patients who rely on access to plasma protein therapies. These unique, non-interchangeable and lifesaving therapies treat patients with rare diseases such as primary immune deficiency and bleeding disorders, like hemophilia. The executive order on favored nations would use pricing schemes from countries that often do not make the PPTs used by U.S. patients available, often selecting only one representative drug in a category and artificially setting prices.
Read More
EU Health Commissioner Says Plasma Donation is “More Important Than Ever” +

The Plasma Protein Therapeutics Association (PPTA) welcomes EU Health Commissioner Kyriakides’ recognition of the importance of plasma donation in her observance yesterday of World Blood Donor Day. By noting plasma’s role in the manufacture of plasma-derived medicinal therapies (PDMPs) for people with a range of life-challenging diseases, as well as its potential role in treating people with COVID-19, Commissioner Kyriakides rightly notes that “donating plasma is therefore now more important than ever.”
Read More

1
2
3

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published quarterly.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap